Antibiotic prophylaxis in primary hip and knee arthroplasty. Comparison between cefuroxime and two specific antistaphylococcal agents

Journal of Arthroplasty

Volumn 25, Issue 7, 2010, Pages 1078-1082

  Tyllianakis, Minos E ^a   Karageorgos, Athanasios Ch ^b   Marangos, Markos N ^a   Saridis, Alkis G ^a   Lambiris, Elias E ^a  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^b Hospital of Pyrgos   (Greece)

Author keywords

Cefuroxime; Fusidic acid; Methicillin resistant staphylococci; Prophylactic antibiosis; Vancomycin

Indexed keywords

CEFUROXIME; FUSIDIC ACID; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS EPIDERMIDIS; PREVALENCE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STAPHYLOCOCCUS EPIDERMIDIS; SURGICAL INFECTION; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; URINARY TRACT INFECTION;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; CEFUROXIME; FUSIDIC ACID; HIP PROSTHESIS; HUMANS; INCIDENCE; KNEE PROSTHESIS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTHESIS-RELATED INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS; TREATMENT OUTCOME; VANCOMYCIN;

EID: 77957256923     PISSN: 08835403     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arth.2010.01.105     Document Type: Article

References (19)

1. Malchau H., Herberts P., Ahnfelt L. Prognosis of total hip replacement in Sweden. Follow-up of 92,675 operations performed 1978-1990. Acta Orthop Scand 1993, 64:497.
2. Maderazo E.G., Judson S., Pasternak H. Late infections of total joint prostheses. A review and recommendations for prevention. Clin Orthop Relat Res 1988, 131.
3. Hill C., Flamant R., Mazas F., et al. Prophylactic cefazolin versus placebo in total hip replacement. Report of a multicentre double-blind randomised trial. Lancet 1981, 1:795.
4. Doyon F., Evrard J., Mazas F., et al. Long-term results of prophylactic cefazolin versus placebo in total hip replacement. Lancet 1987, 1:860.
5. Doyon F., Evrard J., Mazas F. Evaluation of therapeutic trials published apropos of antibiotic prophylaxis in orthopedic surgery. Rev Chir Orthop Reparatrice Appar Mot 1989, 75:72. [Review].
6. Heath A.F. Antimicrobial prophylaxis for arthroplasty and total joint replacement: discussion and review of published clinical trials. Pharmacotherapy 1991, 11:157. (51/7).
7. Fitzgerald R.H., Thompson R.L. Cephalosporin antibiotics in the prevention and treatment of musculoskeletal sepsis. J Bone Joint Surg Am 1983, 65:1201.
8. Gross P.A., Barrett T.L., Dellinger E.P., et al. Purpose of quality standards for infectious diseases. Infectious Diseases Society of America. Clin Infect Dis. 1994, 18:421.
9. Poss R., Thornhill T.S., Ewald F.C., et al. Factors influencing the incidence and outcome of infection following total joint arthroplasty. Clin Orthop Relat Res 1984, 117.
10. Wilson M.G., Kelley K., Thornhill T.S. Infection as a complication of total knee-replacement arthroplasty. Risk factors and treatment in sixty-seven cases. J Bone Joint Surg Am 1990, 72:878.
11. England S.P., Stern S.H., Insall J.N., et al. Total knee arthroplasty in diabetes mellitus. Clin Orthop Relat Res 1990, 130.
12. Papagelopoulos P.J., Idusuyi O.B., Wallrichs S.L., et al. Long term outcome and survivorship analysis of primary total knee arthroplasty in patients with diabetes mellitus. Clin Orthop Relat Res 1996, 124.
13. Cruse P.J., Foord R. A five-year prospective study of 23,649 surgical wounds. Arch Surg. 1973, 107:206.
14. Charnley J., Eftekhar N. Postoperative infection in total prosthetic replacement arthroplasty of the hip-joint. With special reference to the bacterial content of the air of the operating room. Br J Surg 1969, 56:641.
15. Rand J.A., Chao E.Y., Stauffer R.N. Kinematic rotating-hinge total knee arthroplasty. J Bone Joint Surg Am 1987, 69:489.
16. Bryan C.S., Morgan S.L., Caton R.J., et al. Cefazolin versus cefamandole for prophylaxis during total joint arthroplasty. Clin Orthop Relat Res 1988, 117.
17. Mauerhan D.R., Nelson C.L., Smith D.L., et al. Prophylaxis against infection in total joint arthroplasty. One day of cefuroxime compared with three days of cefazolin. J Bone Joint Surg Am 1994, 76:39.
18. Eshkenazi A.U., Garti A., Tamir L., et al. Serum and synovial vancomycin concentrations following prophylactic administration in knee arthroplasty. Am J Knee Surg 2001, 14:221.
19. Burke J.F. The effective period of preventive antibiotic action in experimental incisions and dermal lesions. Surgery 1961, 50:161.